🇺🇸 FDA
Patent

US 10086061

Combination purified inactivated vaccine for flaviviruses

granted A61KA61K2039/5252A61K2039/545

Quick answer

US patent 10086061 (Combination purified inactivated vaccine for flaviviruses) held by The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research
Grant date
Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/5252, A61K2039/545, A61K2039/70, A61K39/12